The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...

Before beginning the discussion of where this company is going, let's set expectations appropriately. Moderna won't be ...

RNA vaccine developer Moderna (MRNA) is climbing nearly 5% in early trading today after it was awarded about $590 million by the U.S.

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna gets a $590 million federal boost to continue work on development of a vaccine to protect against bird flu.

Moderna is set to receive $590m in funding from the US Department of Health and Human Services (HHS) to expedite the ...